SKB103 for Injection in Advanced Solid Tumors

NCT07459998 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SKB103 for injection monotherapy

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.